Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 123

1.

RHAMM, a receptor for hyaluronan-mediated motility, compensates for CD44 in inflamed CD44-knockout mice: a different interpretation of redundancy.

Nedvetzki S, Gonen E, Assayag N, Reich R, Williams RO, Thurmond RL, Huang JF, Neudecker BA, Wang FS, Turley EA, Naor D.

Proc Natl Acad Sci U S A. 2004 Dec 28;101(52):18081-6. Epub 2004 Dec 13. Erratum in: Proc Natl Acad Sci U S A. 2005 Jan 25;102(4):1263. Wang, Fu-Shang [corrected to Wang, Fu-Sheng].

2.
3.

Differential involvement of the hyaluronan (HA) receptors CD44 and receptor for HA-mediated motility in endothelial cell function and angiogenesis.

Savani RC, Cao G, Pooler PM, Zaman A, Zhou Z, DeLisser HM.

J Biol Chem. 2001 Sep 28;276(39):36770-8. Epub 2001 Jul 11.

5.

Rhamm-/- fibroblasts are defective in CD44-mediated ERK1,2 motogenic signaling, leading to defective skin wound repair.

Tolg C, Hamilton SR, Nakrieko KA, Kooshesh F, Walton P, McCarthy JB, Bissell MJ, Turley EA.

J Cell Biol. 2006 Dec 18;175(6):1017-28. Epub 2006 Dec 11.

6.

Receptor for hyaluronan-mediated motility (RHAMM), a hyaladherin that regulates cell responses to growth factors.

Cheung WF, Cruz TF, Turley EA.

Biochem Soc Trans. 1999 Feb;27(2):135-42. Review. No abstract available.

PMID:
10093722
7.

Potential role for hyaluronan and the hyaluronan receptor RHAMM in mobilization and trafficking of hematopoietic progenitor cells.

Pilarski LM, Pruski E, Wizniak J, Paine D, Seeberger K, Mant MJ, Brown CB, Belch AR.

Blood. 1999 May 1;93(9):2918-27.

8.

Loss of the hyaluronan receptor RHAMM prevents constrictive artery wall remodeling.

Ma X, Pearce JD, Wilson DB, English WP, Edwards MS, Geary RL.

J Vasc Surg. 2014 Mar;59(3):804-13. doi: 10.1016/j.jvs.2013.03.047. Epub 2013 Jun 12.

9.

The human hyaluronan receptor RHAMM is expressed as an intracellular protein in breast cancer cells.

Assmann V, Marshall JF, Fieber C, Hofmann M, Hart IR.

J Cell Sci. 1998 Jun;111 ( Pt 12):1685-94.

10.

The mechanism of molecular redundancy in autoimmune inflammation in the context of CD44 deficiency.

Naor D, Nedvetzki S, Assayag N, Thurmond RL, Huang JF, Turley EA.

Ann N Y Acad Sci. 2005 Jun;1050:52-63. Review.

PMID:
16014520
11.

Identification of sequence, protein isoforms, and distribution of the hyaluronan-binding protein RHAMM in adult and developing rat brain.

Lynn BD, Li X, Cattini PA, Turley EA, Nagy JI.

J Comp Neurol. 2001 Oct 22;439(3):315-30.

PMID:
11596057
12.

RHAMM/ERK interaction induces proliferative activities of cementifying fibroma cells through a mechanism based on the CD44-EGFR.

Hatano H, Shigeishi H, Kudo Y, Higashikawa K, Tobiume K, Takata T, Kamata N.

Lab Invest. 2011 Mar;91(3):379-91. doi: 10.1038/labinvest.2010.176. Epub 2010 Oct 18.

13.

Expression of hyaluronan receptors CD44 and RHAMM in stomach cancers: relevance with tumor progression.

Li H, Guo L, Li JW, Liu N, Qi R, Liu J.

Int J Oncol. 2000 Nov;17(5):927-32.

PMID:
11029494
14.

Differential expression of the hyaluronan receptors CD44 and RHAMM in human pancreatic cancer cells.

Abetamann V, Kern HF, Elsässer HP.

Clin Cancer Res. 1996 Sep;2(9):1607-18.

15.

CD44 involvement in autoimmune inflammations: the lesson to be learned from CD44-targeting by antibody or from knockout mice.

Naor D, Nedvetzki S, Walmsley M, Yayon A, Turley EA, Golan I, Caspi D, Sebban LE, Zick Y, Garin T, Karussis D, Assayag-Asherie N, Raz I, Weiss L, Slavin S, Golan I.

Ann N Y Acad Sci. 2007 Sep;1110:233-47. Review.

PMID:
17911438
16.

Selective expression of hyaluronan and receptor for hyaluronan mediated motility (Rhamm) in the adult mouse subventricular zone and rostral migratory stream and in ischemic cortex.

Lindwall C, Olsson M, Osman AM, Kuhn HG, Curtis MA.

Brain Res. 2013 Mar 29;1503:62-77. doi: 10.1016/j.brainres.2013.01.045. Epub 2013 Feb 4.

PMID:
23391595
18.

The characterization of a human RHAMM cDNA: conservation of the hyaluronan-binding domains.

Wang C, Entwistle J, Hou G, Li Q, Turley EA.

Gene. 1996 Oct 3;174(2):299-306.

PMID:
8890751
19.

Toll-like receptor 2 (TLR2), transforming growth factor-β, hyaluronan (HA), and receptor for HA-mediated motility (RHAMM) are required for surfactant protein A-stimulated macrophage chemotaxis.

Foley JP, Lam D, Jiang H, Liao J, Cheong N, McDevitt TM, Zaman A, Wright JR, Savani RC.

J Biol Chem. 2012 Oct 26;287(44):37406-19. doi: 10.1074/jbc.M112.360982. Epub 2012 Sep 4.

20.

Regulation of ciliary differentiation of human respiratory epithelial cells by the receptor for hyaluronan-mediated motility on hyaluronan-based biomaterials.

Huang TW, Cheng PW, Chan YH, Yeh TH, Young YH, Young TH.

Biomaterials. 2010 Sep;31(26):6701-9. doi: 10.1016/j.biomaterials.2010.05.054. Epub 2010 Jun 17.

PMID:
20619784

Supplemental Content

Support Center